Company & Sponsor Intelligence

University Medical Center Groningen

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting3

Completed2

Countries3

Therapeutic footprint

alzheimersdepressionother_psychiatryparkinsonsschizophrenia

Indexed studies

NCT05853471[18F]MC225-PET in Neurodegenerative Disease
alzheimers · NetherlandsPHASE1, PHASE2

NCT01630512Mindfulness-Based Cognitive Therapy (MBCT) and Cognitive Behavioral Therapy (CBT) for Depression in Diabetes Patients
depression · NetherlandsNA

NCT06692530Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
schizophrenia · NetherlandsRECRUITING

NCT06782724Psilocybin Therapy for Psychological Distress in Palliative Patients
parkinsons · CzechiaPHASE2

NCT05395559Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
alzheimers · NetherlandsCOMPLETED

NCT07373223Virtual Reality Schema Therapy Exercises With Parent and Child Modes
other_psychiatry · NetherlandsNA

NCT03532984Beam Walking Across the Lifespan for Falls Prediction
parkinsons · BrazilUNKNOWN

NCT04295889Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches
alzheimers · NetherlandsNA

NCT04180865The Dutch Parkinson and Cognition Study
parkinsons · NetherlandsUNKNOWN

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →